The DOI matches its Crossref record; 196 of the 196 references it cites were found in a registry or an index.
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Open accessAbstract
Nonalcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver disease in industrialized countries worldwide, and has become a serious public health issue not only in Western countries but also in many Asian countries including Japan. Within the wide spectrum of NAFLD, nonalcoholic steatohepatitis (NASH) is a progressive form of disease, which often develops into liver cirrhosis and increases the risk of hepatocellular carcinoma. In turn, a large proportion of NAFLD/NASH is the liver manifestation of metabolic syndrome, suggesting that NAFLD/NASH plays a key role in the pathogenesis of systemic atherosclerotic diseases. Currently, a definite diagnosis of NASH requires liver biopsy, though various noninvasive measures are under development. The mainstays of prevention and treatment of NAFLD/NASH include dietary restriction and exercise; however, pharmacological approaches are often necessary. Currently, vitamin E and thiazolidinedione derivatives are the most evidence-based therapeutic options, although the clinical evidence for long-term efficacy and safety is limited. This practice guideline for NAFLD/NASH, established by the Japanese Society of Gastroenterology in cooperation with The Japan Society of Hepatology, covers lines of clinical evidence reported internationally in the period starting from 1983 to January 2012, and each clinical question was evaluated using the GRADE system. Based on the primary release of the full version in Japanese, this English summary provides the core essentials of this clinical practice guideline comprising the definition, diagnosis, and current therapeutic recommendations for NAFLD/NASH in Japan.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Angelico, F., Burattin, M., Alessandri, C., Ben, M. D., & Lirussi, F. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005166.pub2 · Cited by 119
RetractedDesign and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Angulo, P., Hui, J. M., Marchesini, G., Bugianesi, E., George, J., Farrell, G. C., Enders, F., Saksena, S., Burt, A. D., Bida, J. P., et al. (2007) · Hepatology · doi:10.1002/hep.21496 · Cited by 3,203
Vernon, G., Baranova, A., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,074
Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
Tilg, H., & Moschen, A. R. (2010) · Hepatology · doi:10.1002/hep.24001 · Cited by 2,548
Reactive oxygen species have a causal role in multiple forms of insulin resistance
Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525
Vilar-Gomez, E., Martinez-Perez, Y., Calzadilla-Bertot, L., Torres-Gonzalez, A., Gra-Oramas, B., Gonzalez-Fabian, L., Friedman, S. L., Diago, M., & Romero-Gomez, M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.005 · Cited by 2,492
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302
Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237
Armstrong, M. J., Gaunt, P., Aithal, G. P., Barton, D., Hull, D., Parker, R., Hazlehurst, J. M., Guo, K., Abouda, G., Aldersley, M. A., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00803-x · Cited by 2,203
Williams, C. D., Stengel, J., Asike, M. I., Torres, D. M., Shaw, J., Contreras, M., Landt, C. L., & Harrison, S. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.09.038 · Cited by 2,148
The utility of radiological imaging in nonalcoholic fatty liver disease
Saadeh, S., Younossi, Z. M., Remer, E. M., Gramlich, T., Ong, J. P., Hurley, M., Mullen, K. D., Cooper, J. N., & Sheridan, M. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.35354 · Cited by 2,110
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease
Ratziu, V., Charlotte, F., Heurtier, A., Gombert, S., Giral, P., Bruckert, E., Grimaldi, A., Capron, F., & Poynard, T. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.084 · Cited by 2,106
Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates
Sacks, F. M., Bray, G. A., Carey, V. J., Smith, S. R., Ryan, D. H., Anton, S. D., McManus, K., Champagne, C. M., Bishop, L. M., Laranjo, N., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804748 · Cited by 1,966 · cited 1×
“calorie diets promotes weight loss, and that caloric restriction is more important than the proportions of carbohydrates and lipids for weight loss [67].”
BackgroundA placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060326 · Cited by 1,827
Wong, R. J., Aguilar, M., Cheung, R., Perumpail, R. B., Harrison, S. A., Younossi, Z. M., & Ahmed, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.11.039 · Cited by 1,819
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
Angulo, P., Keach, J. C., Batts, K. P., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510300604 · Cited by 1,610
Hernaez, R., Lazo, M., Bonekamp, S., Kamel, I., Brancati, F. L., Guallar, E., & Clark, J. M. (2011) · Hepatology · doi:10.1002/hep.24452 · Cited by 1,585
Boursier, J., Mueller, O., Barret, M., Machado, M., Fizanne, L., Araujo‐Perez, F., Guy, C. D., Seed, P. C., Rawls, J. F., David, L. A., et al. (2016) · Hepatology · doi:10.1002/hep.28356 · Cited by 1,483
Bugianesi, E., Leone, N., Vanni, E., Marchesini, G., Brunello, F., Carucci, P., Musso, A., De Paolis, P., Capussotti, L., Salizzoni, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.34168 · Cited by 1,439
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
Targher, G., Byrne, C. D., Lonardo, A., Zoppini, G., & Barbui, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.013 · Cited by 1,424
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
Promrat, K., Kleiner, D. E., Niemeier, H. M., Jackvony, E., Kearns, M., Wands, J. R., Fava, J. L., & Wing, R. R. (2010) · Hepatology · doi:10.1002/hep.23276 · Cited by 1,330
Ascha, M. S., Hanouneh, I. A., Lopez, R., Tamimi, T. A.-R., Feldstein, A. F., & Zein, N. N. (2010) · Hepatology · doi:10.1002/hep.23527 · Cited by 1,296
Musso, G., Gambino, R., Cassader, M., & Pagano, G. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.518623 · Cited by 1,293
Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy
Bellentani, S., Saccoccio, G., Masutti, F., Crocè, L. S., Brandi, G., Sasso, F., Cristanini, G., & Tiribelli, C. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00004 · Cited by 1,265
Kozlitina, J., Smagris, E., Stender, S., Nordestgaard, B. G., Zhou, H. H., Tybjærg-Hansen, A., Vogt, T. F., Hobbs, H. H., & Cohen, J. C. (2014) · Nature Genetics · doi:10.1038/ng.2901 · Cited by 1,234
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
El-serag, H. B., Tran, T., & Everhart, J. E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.065 · Cited by 1,230
Mofrad, P., Contos, M. J., Haque, M., Sargeant, C., Fisher, R. A., Luketic, V. A., Sterling, R. K., Shiffman, M. L., Stravitz, R. T., & Sanyal, A. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50229 · Cited by 1,201
Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying Disease
Caldwell, S. H., Oelsner, D. H., Iezzoni, J. C., Hespenheide, E. E., Battle, E. H., & Driscoll, C. J. (1999) · Hepatology · doi:10.1002/hep.510290347 · Cited by 1,143
Charlton, M. R., Burns, J. M., Pedersen, R. A., Watt, K. D., Heimbach, J. K., & Dierkhising, R. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.061 · Cited by 1,106
Lavine, J. E. (2011) · JAMA · doi:10.1001/jama.2011.520 · Cited by 1,101
AGA technical review on nonalcoholic fatty liver disease
Sanyal, A. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36572 · Cited by 1,072
The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease
Hamaguchi, M., Kojima, T., Takeda, N., Nakagawa, T., Taniguchi, H., Fujii, K., Omatsu, T., Nakajima, T., Sarui, H., Shimazaki, M., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-10-200511150-00009 · Cited by 1,062
McPherson, S., Hardy, T., Henderson, E., Burt, A. D., Day, C. P., & Anstee, Q. M. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.034 · Cited by 1,060
A position statement on NAFLD/NASH based on the EASL 2009 special conference
Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C., & Marchesini, G. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.008 · Cited by 1,058
Ratziu, V., Harrison, S. A., Francque, S., Bedossa, P., Lehert, P., Serfaty, L., Romero-Gomez, M., Boursier, J., Abdelmalek, M., Caldwell, S., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.038 · Cited by 1,035
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis
Rolo, A. P., Teodoro, J. S., & Palmeira, C. M. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.003 · Cited by 955
Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis
McPherson, S., Hardy, T., Dufour, J.-F., Petta, S., Romero-Gomez, M., Allison, M., Oliveira, C. P., Francque, S., Van Gaal, L., Schattenberg, J. M., et al. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.453 · Cited by 945
The natural history of nonalcoholic fatty liver: A follow-up study
Teli, M. R., James, O. F. W., Burt, A. D., Bennett, M. K., & Day, C. P. (1995) · Hepatology · doi:10.1002/hep.1840220616 · Cited by 925
Imajo, K., Kessoku, T., Honda, Y., Tomeno, W., Ogawa, Y., Mawatari, H., Fujita, K., Yoneda, M., Taguri, M., Hyogo, H., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.11.048 · Cited by 812
Self-citationRyan, M. C., Itsiopoulos, C., Thodis, T., Ward, G., Trost, N., Hofferberth, S., O’Dea, K., Desmond, P. V., Johnson, N. A., & Wilson, A. M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.012 · Cited by 778
Decreased Survival of Subjects With Elevated Liver Function Tests During A 28-Year Follow-Up
Söderberg, C., Stål, P., Askling, J., Glaumann, H., Lindberg, G., Marmur, J., & Hultcrantz, R. (2010) · Hepatology · doi:10.1002/hep.23314 · Cited by 754
Guha, I. N., Parkes, J., Roderick, P., Chattopadhyay, D., Cross, R., Harris, S., Kaye, P., Burt, A. D., Ryder, S. D., Aithal, G. P., et al. (2008) · Hepatology · doi:10.1002/hep.21984 · Cited by 745
Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver
Rafiq, N., Bai, C., Fang, Y., Srishord, M., McCullough, A., Gramlich, T., & Younossi, Z. M. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.11.005 · Cited by 729
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial
Lindor, K. D., Kowdley, K. V., Heathcote, J. E., Harrison, E. M., Jorgensen, R., Angulo, P., Lymp, J. F., Burgart, L., & Colin, P. (2004) · Hepatology · doi:10.1002/hep.20092 · Cited by 727 · cited 1×
“An RCT for UDCA at conventional doses for NASH was reported in 2004, and conventional doses of UDCA did not show any beneficial effects on serum biochemical indices and hepatic histology in patients with NASH [84].”
BackgroundFeldstein, A. E., Charatcharoenwitthaya, P., Treeprasertsuk, S., Benson, J. T., Enders, F. B., & Angulo, P. (2009) · Gut · doi:10.1136/gut.2008.171280 · Cited by 726
Aithal, G. P., Thomas, J. A., Kaye, P. V., Lawson, A., Ryder, S. D., Spendlove, I., Austin, A. S., Freeman, J. G., Morgan, L., & Webber, J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.06.047 · Cited by 721 · cited 1×
“In regard to the effect of thiazolidinediones, there have been four RCTs, three for pioglitazone [62, 63, 70] and one for rosiglitazone [4], and both drugs have had their efficacy against NASH confirmed by assessment of hepatic pathologic changes including steatosis, ballooning, and lobular inflammation.”
BackgroundMancina, R. M., Dongiovanni, P., Petta, S., Pingitore, P., Meroni, M., Rametta, R., Borén, J., Montalcini, T., Pujia, A., Wiklund, O., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.032 · Cited by 676
Wieckowska, A., Zein, N. N., Yerian, L. M., Lopez, R. A., McCullough, A. J., & Feldstein, A. E. (2006) · Hepatology · doi:10.1002/hep.21223 · Cited by 670
Musso, G., Cassader, M., Rosina, F., & Gambino, R. (2012) · Diabetologia · doi:10.1007/s00125-011-2446-4 · Cited by 661
Johnson, N. A., Sachinwalla, T., Walton, D. W., Smith, K., Armstrong, A., Thompson, M. W., & George, J. (2009) · Hepatology · doi:10.1002/hep.23129 · Cited by 631
Drinking habits as cofactors of risk for alcohol induced liver damage
Bellentani, S., Saccoccio, G., Costa, G., Tiribelli, C., Manenti, F., Sodde, M., Croce’, L. S., Sasso, F., Pozzato, G., Cristianini, G., et al. (1997) · Gut · doi:10.1136/gut.41.6.845 · Cited by 630 · cited 1×
“Epidemiological studies have shown that alcoholic liver disease can occur when the daily alcohol intake exceeds 20 g in women and 30 g in men [12, 13].”
BackgroundHe, S., McPhaul, C., Li, J. Z., Garuti, R., Kinch, L., Grishin, N. V., Cohen, J. C., & Hobbs, H. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.064501 · Cited by 610
Ethnic Differences in the Relationship Between Insulin Sensitivity and Insulin Response
Kodama, K., Tojjar, D., Yamada, S., Toda, K., Patel, C. J., & Butte, A. J. (2013) · Diabetes Care · doi:10.2337/dc12-1235 · Cited by 599
Targher, G., Bertolini, L., Poli, F., Rodella, S., Scala, L., Tessari, R., Zenari, L., & Falezza, G. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3541 · Cited by 574
A Meta-Analysis of Randomized Trials for the Treatment of Nonalcoholic Fatty Liver Disease
Musso, G., Gambino, R., Cassader, M., & Pagano, G. (2010) · Hepatology · doi:10.1002/hep.23623 · Cited by 564
Francque, S. M., van der Graaff, D., & Kwanten, W. J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.005 · Cited by 556
JSG-NAFLD, Eguchi, Y., Hyogo, H., Ono, M., Mizuta, T., Ono, N., Fujimoto, K., Chayama, K., & Saibara, T. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-012-0533-z · Cited by 551
Self-citationNonalcoholic fatty liver disease is a novel predictor of cardiovascular disease
Hamaguchi, M. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i10.1579 · Cited by 542
Dongiovanni, P., Petta, S., Maglio, C., Fracanzani, A. L., Pipitone, R., Mozzi, E., Motta, B. M., Kaminska, D., Rametta, R., Grimaudo, S., et al. (2015) · Hepatology · doi:10.1002/hep.27490 · Cited by 533
Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study
Lavine, J. E. (2000) · The Journal of Pediatrics · doi:10.1016/s0022-3476(00)05040-x · Cited by 531
Thoma, C., Day, C. P., & Trenell, M. I. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.06.010 · Cited by 523
Cassinotto, C., Boursier, J., de Lédinghen, V., Lebigot, J., Lapuyade, B., Cales, P., Hiriart, J., Michalak, S., Bail, B. L., Cartier, V., et al. (2016) · Hepatology · doi:10.1002/hep.28394 · Cited by 521
Effect of bariatric surgery on nonalcoholic fatty liver disease: Systematic review and meta-analysis
Mummadi, R. R., Kasturi, K. S., Chennareddygari, S., & Sood, G. K. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.08.012 · Cited by 511
Harnois, D. (2009) · Yearbook of Gastroenterology · doi:10.1016/s0739-5930(09)79298-0 · Cited by 505
Yokohama, S., Yoneda, M., Haneda, M., Okamoto, S., Okada, M., Aso, K., Hasegawa, T., Tokusashi, Y., Miyokawa, N., & Nakamura, K. (2004) · Hepatology · doi:10.1002/hep.20420 · Cited by 458
Self-citationGlucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis
Armstrong, M. J., Hull, D., Guo, K., Barton, D., Hazlehurst, J. M., Gathercole, L. L., Nasiri, M., Yu, J., Gough, S. C., Newsome, P. N., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.08.038 · Cited by 456
Jimba, S., Nakagami, T., Takahashi, M., Wakamatsu, T., Hirota, Y., Iwamoto, Y., & Wasada, T. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01582.x · Cited by 455
Kojima, S.-I., Watanabe, N., Numata, M., Ogawa, T., & Matsuzaki, S. (2003) · Journal of Gastroenterology · doi:10.1007/s00535-003-1178-8 · Cited by 455
Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis
Koo, B. K., Kim, D., Joo, S. K., Kim, J. H., Chang, M. S., Kim, B. G., Lee, K. L., & Kim, W. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.08.019 · Cited by 440
Sanyal, A. J., Mofrad, P. S., Contos, M. J., Sargeant, C., Luketic, V. A., Sterling, R. K., Stravitz, R. T., Shiffman, M. L., Clore, J., & Mills, A. S. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00457-4 · Cited by 437
Yoneda, M., Yoneda, M., Mawatari, H., Fujita, K., Endo, H., Iida, H., Nozaki, Y., Yonemitsu, K., Higurashi, T., Takahashi, H., et al. (2008) · Digestive and Liver Disease · doi:10.1016/j.dld.2007.10.019 · Cited by 428
Self-citationHasegawa, T., Yoneda, M., Nakamura, K., Makino, I., & Terano, A. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01083.x · Cited by 408
Self-citationSvegliati‐Baroni, G., Saccomanno, S., Rychlicki, C., Agostinelli, L., De Minicis, S., Candelaresi, C., Faraci, G., Pacetti, D., Vivarelli, M., Nicolini, D., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02462.x · Cited by 405
Metformin in the treatment of patients with non‐alcoholic steatohepatitis
Uygun, A., Kadayifci, A., Isik, A. T., Ozgurtas, T., Deveci, S., Tuzun, A., Yesilova, Z., Gulsen, M., & Dagalp, K. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01888.x · Cited by 405
Statin use and non-alcoholic steatohepatitis in at risk individuals
Dongiovanni, P., Petta, S., Mannisto, V., Mancina, R. M., Pipitone, R., Karja, V., Maggioni, M., Kakela, P., Wiklund, O., Mozzi, E., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.05.006 · Cited by 390
Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population
Sumida, Y., Yoneda, M., Hyogo, H., Itoh, Y., Ono, M., Fujii, H., Eguchi, Y., Suzuki, Y., Aoki, N., Kanemasa, K., et al. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-2 · Cited by 383
Self-citationGI Epidemiology: nonalcoholic fatty liver disease
ANGULO, P. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03246.x · Cited by 369
Lazo, M., Solga, S. F., Horska, A., Bonekamp, S., Diehl, A. M., Brancati, F. L., Wagenknecht, L. E., Pi-Sunyer, F. X., Kahn, S. E., Clark, J. M., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0856 · Cited by 367
Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial
Zein, C. O., Yerian, L. M., Gogate, P., Lopez, R., Kirwan, J. P., Feldstein, A. E., & McCullough, A. J. (2011) · Hepatology · doi:10.1002/hep.24544 · Cited by 356
A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis
Ratziu, V., de Ledinghen, V., Oberti, F., Mathurin, P., Wartelle-Bladou, C., Renou, C., Sogni, P., Maynard, M., Larrey, D., Serfaty, L., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.030 · Cited by 338
Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial
Cui, J., Philo, L., Nguyen, P., Hofflich, H., Hernandez, C., Bettencourt, R., Richards, L., Salotti, J., Bhatt, A., Hooker, J., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.021 · Cited by 326
Merriman, R. B., Ferrell, L. D., Patti, M. G., Weston, S. R., Pabst, M. S., Aouizerat, B. E., & Bass, N. M. (2006) · Hepatology · doi:10.1002/hep.21346 · Cited by 324
Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
Haukeland, J. W., Konopski, Z., Eggesbø, H. B., von Volkmann, H. L., Raschpichler, G., Bjøro, K., Haaland, T., Løberg, E. M., & Birkeland, K. (2009) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520902845268 · Cited by 323
Boettcher, E., Csako, G., Pucino, F., Wesley, R., & Loomba, R. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04912.x · Cited by 318
Leuschner, U. F. H., Lindenthal, B., Herrmann, G., Arnold, J. C., Rössle, M., Cordes, H., Zeuzem, S., Hein, J., & Berg, T. (2010) · Hepatology · doi:10.1002/hep.23727 · Cited by 317
Chitturi, S., Farrell, G. C., Hashimoto, E., Saibara, T., Lau, G. K., Sollano, J. D., & NAFLD, T. A. W. P. O. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05001.x · Cited by 312
Self-citationChen, C.-H., Huang, M.-H., Yang, J.-C., Nien, C.-K., Yang, C.-C., Yeh, Y.-H., & Yueh, S.-K. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200609000-00016 · Cited by 294
Valenti, L., Alisi, A., Galmozzi, E., Bartuli, A., Del Menico, B., Alterio, A., Dongiovanni, P., Fargion, S., & Nobili, V. (2010) · Hepatology · doi:10.1002/hep.23823 · Cited by 291
Valenti, L., Fracanzani, A. L., Dongiovanni, P., Bugianesi, E., Marchesini, G., Manzini, P., Vanni, E., & Fargion, S. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01192.x · Cited by 290
Kawamura, Y., Arase, Y., Ikeda, K., Seko, Y., Imai, N., Hosaka, T., Kobayashi, M., Saitoh, S., Sezaki, H., Akuta, N., et al. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.327 · Cited by 280
Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD)
Yoneda, M., Fujita, K., Inamori, M., Nakajima, A., Tamano, M., & Hiraishi, H. (2007) · Gut · doi:10.1136/gut.2007.126417 · Cited by 278
Self-citationSafadi, R., Konikoff, F. M., Mahamid, M., Zelber-Sagi, S., Halpern, M., Gilat, T., Oren, R., Safadi, R., Konikoff, F. M., Hershkovitz, A., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.04.038 · Cited by 274
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.02.013 · Cited by 272
Advances in Pediatric Nonalcoholic Fatty Liver Disease†
Loomba, R., Sirlin, C. B., Schwimmer, J. B., & Lavine, J. E. (2009) · Hepatology · doi:10.1002/hep.23119 · Cited by 264
Kawaguchi, T., Sumida, Y., Umemura, A., Matsuo, K., Takahashi, M., Takamura, T., Yasui, K., Saibara, T., Hashimoto, E., Kawanaka, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038322 · Cited by 264
Self-citationPrevalence, gender, ethnic variations, and prognosis of NASH
Hashimoto, E., & Tokushige, K. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-010-0311-8 · Cited by 264
Self-citationFoster, T., Budoff, M. J., Saab, S., Ahmadi, N., Gordon, C., & Guerci, A. D. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.299 · Cited by 260
van der Heijden, G., Wang, Z. J., Chu, Z. D., Sauer, P. J. J., Haymond, M. W., Rodriguez, L. M., & Sunehag, A. L. (2010) · Obesity · doi:10.1038/oby.2009.274 · Cited by 253
Coffee Reduces Risk for Hepatocellular Carcinoma: An Updated Meta-analysis
Bravi, F., Bosetti, C., Tavani, A., Gallus, S., & La Vecchia, C. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.04.039 · Cited by 253
Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction
Adams, L. A., Feldstein, A., Lindor, K. D., & Angulo, P. (2004) · Hepatology · doi:10.1002/hep.20140 · Cited by 252
Athyros, V. G., Mikhailidis, D. P., Didangelos, T. P., Giouleme, O. I., Liberopoulos, E. N., Karagiannis, A., Kakafika, A. I., Tziomalos, K., Burroughs, A. K., & Elisaf, M. S. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x104696 · Cited by 248
Facchini, F. S., Hua, N. W., & Stoohs, R. A. (2002) · Gastroenterology · doi:10.1053/gast.2002.32403 · Cited by 233
Farrell, G. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-30106 · Cited by 231
Yalamanchili, K., Saadeh, S., Klintmalm, G. B., Jennings, L. W., & Davis, G. L. (2010) · Liver Transplantation · doi:10.1002/lt.22004 · Cited by 227
Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo‐controlled trial†
Abdelmalek, M. F., Sanderson, S. O., Angulo, P., Soldevila‐Pico, C., Liu, C., Peter, J., Keach, J., Cave, M., Chen, T., McClain, C. J., et al. (2009) · Hepatology · doi:10.1002/hep.23239 · Cited by 225
Pingitore, P., Pirazzi, C., Mancina, R. M., Motta, B. M., Indiveri, C., Pujia, A., Montalcini, T., Hedfalk, K., & Romeo, S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.12.006 · Cited by 212
Ishibashi, S., Yamashita, S., Arai, H., Araki, E., Yokote, K., Suganami, H., Fruchart, J.-C., & Kodama, T. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.02.029 · Cited by 208
Outcome After Liver Transplantation for NASH Cirrhosis
Malik, S. M., DeVera, M. E., Fontes, P., Shaikh, O., & Ahmad, J. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02590.x · Cited by 207
Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia
Hyogo, H., Tazuma, S., Arihiro, K., Iwamoto, K., Nabeshima, Y., Inoue, M., Ishitobi, T., Nonaka, M., & Chayama, K. (2008) · Metabolism · doi:10.1016/j.metabol.2008.07.030 · Cited by 206
Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis†
Maher, J. J., Leon, P., & Ryan, J. C. (2008) · Hepatology · doi:10.1002/hep.22399 · Cited by 203
Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD), Sumida, Y., Yoneda, M., Hyogo, H., Yamaguchi, K., Ono, M., Fujii, H., Eguchi, Y., Suzuki, Y., Imai, S., et al. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-010-0305-6 · Cited by 199
Self-citationFinal results of a long-term, clinical follow-up in fatty liver patients
Dam-Larsen, S., Becker, U., Franzmann, M.-B., Larsen, K., Christoffersen, P., & Bendtsen, F. (2009) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520903171284 · Cited by 187
Torres, D. M., Jones, F. J., Shaw, J. C., Williams, C. D., Ward, J. A., & Harrison, S. A. (2011) · Hepatology · doi:10.1002/hep.24558 · Cited by 183
Eguchi, Y., Kitajima, Y., Hyogo, H., Takahashi, H., Kojima, M., Ono, M., Araki, N., Tanaka, K., Yamaguchi, M., Matsuda, Y., et al. (2015) · Hepatology Research · doi:10.1111/hepr.12351 · Cited by 182
Self-citationBhagat, V., Mindikoglu, A. L., Nudo, C. G., Schiff, E. R., Tzakis, A., & Regev, A. (2009) · Liver Transplantation · doi:10.1002/lt.21927 · Cited by 182
Georgescu, E. F., Ionescu, R., Niculescu, M., Mogoanta, L., & Vancica, L. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.942 · Cited by 177
Harrison, S. A., Marri, S. R., Chalasani, N., Kohli, R., Aronstein, W., Thompson, G. A., Irish, W., Miles, M. V., Xanthakos, S. A., Lawitz, E., et al. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13816 · Cited by 176
Takahashi, Y., Iida, K., Takahashi, K., Yoshioka, S., Fukuoka, H., Takeno, R., Imanaka, M., Nishizawa, H., Takahashi, M., Seo, Y., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.12.024 · Cited by 175
Hotta, K., Yoneda, M., Hyogo, H., Ochi, H., Mizusawa, S., Ueno, T., Chayama, K., Nakajima, A., Nakao, K., & Sekine, A. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-172 · Cited by 174
Self-citationNonalcoholic steatohepatitis: what we know in the new millennium1
Harrison, S. A., Kadakia, S., Lang, K. A., & Schenker, S. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.07069.x · Cited by 173
Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial
Van Wagner, L. B., Koppe, S. W. P., Brunt, E. M., Gottstein, J., Gardikiotes, K., Green, R. M., & Rinella, M. E. (2011) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31539-x · Cited by 173
Nobili, V., Alisi, A., Panera, N., et al. (2008) · PubMed · Cited by 171
Mahady, S. E., Webster, A. C., Walker, S., Sanyal, A., & George, J. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.03.016 · Cited by 165
NAFLD Recurrence in Liver Transplant Recipients
Dureja, P., Mellinger, J., Agni, R., Chang, F., Avey, G., Lucey, M., & Said, A. (2011) · Transplantation · doi:10.1097/tp.0b013e31820b6b84 · Cited by 160
Meta‐analysis: insulin sensitizers for the treatment of non‐alcoholic steatohepatitis
Rakoski, M. O., Singal, A. G., Rogers, M. A. M., & Conjeevaram, H. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04467.x · Cited by 158
Oh, S., Shida, T., Yamagishi, K., Tanaka, K., So, R., Tsujimoto, T., & Shoda, J. (2015) · Hepatology · doi:10.1002/hep.27544 · Cited by 158
Endocrine and liver interaction: the role of endocrine pathways in NASH
Loria, P., Carulli, L., Bertolotti, M., & Lonardo, A. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.33 · Cited by 150
Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis
Tokushige, K., Takakura, M., Tsuchiya-Matsushita, N., Taniai, M., Hashimoto, E., & Shiratori, K. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.01.028 · Cited by 149
Self-citationEtiology of liver cirrhosis in Japan: a nationwide survey
The Japan Etiology of Liver Cirrhosis Study Group, Michitaka, K., Nishiguchi, S., Aoyagi, Y., Hiasa, Y., Tokumoto, Y., & Onji, M. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0128-5 · Cited by 148
Baranova, A. V., Tran, T., Birerdinc, A., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04579.x · Cited by 148
Kargiotis, K., Athyros, V. G., Giouleme, O., Katsiki, N., Katsiki, E., Anagnostis, P. G., Boutari, C., Doumas, M., Karagiannis, A., & Mikhailidis, D. P. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i25.7860 · Cited by 147
Is weight reduction an effective therapy for nonalcoholic fatty liver?
Wang, R. T., Koretz, R. L., & Yee, H. F. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00449-2 · Cited by 146
Platelet count for predicting fibrosis in nonalcoholic fatty liver disease
Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD), Yoneda, M., Fujii, H., Sumida, Y., Hyogo, H., Itoh, Y., Ono, M., Eguchi, Y., Suzuki, Y., Aoki, N., et al. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-011-0436-4 · Cited by 143
Self-citationEfficacy of ezetimibe for the treatment of non‐alcoholic steatohepatitis: An open‐label, pilot study
Yoneda, M., Fujita, K., Nozaki, Y., Endo, H., Takahashi, H., Hosono, K., Suzuki, K., Mawatari, H., Kirikoshi, H., Inamori, M., et al. (2010) · Hepatology Research · doi:10.1111/j.1872-034x.2010.00644.x · Cited by 140
Self-citationNobili, V., Marcellini, M., Marchesini, G., Vanni, E., Manco, M., Villani, A., & Bugianesi, E. (2007) · Diabetes Care · doi:10.2337/dc07-0281 · Cited by 139
Tanaka, N., Horiuchi, A., Yokoyama, T., Kaneko, G., Horigome, N., Yamaura, T., Nagaya, T., Komatsu, M., Sano, K., Miyagawa, S., et al. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-011-0370-5 · Cited by 131
Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease
Guha, I. N., Parkes, J., Roderick, P., Harris, S., & Rosenberg, W. M. (2006) · Gut · doi:10.1136/gut.2006.091454 · Cited by 128
Tokushige, K., Hashimoto, E., Horie, Y., Taniai, M., & Higuchi, S. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-011-0431-9 · Cited by 124
Self-citationRenin‐angiotensin system and fibrosis in non‐alcoholic fatty liver disease
Goh, G. B., Pagadala, M. R., Dasarathy, J., Ünalp–Arida, A., Sargent, R., Hawkins, C., Sourianarayanane, A., Khiyami, A., Yerian, L. M., Pai, R. K., et al. (2014) · Liver International · doi:10.1111/liv.12611 · Cited by 121
Risk of Cancer in Patients Hospitalized With Fatty Liver
Sørensen, H. T., Mellemkjær, L., Jepsen, P., Thulstrup, A. M., Baron, J. A., Olsen, J. H., & Vilstrup, H. (2003) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200304000-00015 · Cited by 119
Kaneda, H., Hashimoto, E., Yatsuji, S., Tokushige, K., & Shiratori, K. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04447.x · Cited by 119
Self-citationNonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH
Yoshioka, Y., Hashimoto, E., Yatsuji, S., Kaneda, H., Taniai, M., Tokushige, K., & Shiratori, K. (2004) · Journal of Gastroenterology · doi:10.1007/s00535-004-1475-x · Cited by 115
Self-citationPersistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis
Sinn, D. H., Cho, S. J., Gu, S., Seong, D., Kang, D., Kim, H., Yi, B.-K., Paik, S. W., Güallar, E., Cho, J., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.06.001 · Cited by 115
Ochi, H., Hirooka, M., Koizumi, Y., Miyake, T., Tokumoto, Y., Soga, Y., Tada, F., Abe, M., Hiasa, Y., & Onji, M. (2012) · Hepatology · doi:10.1002/hep.25756 · Cited by 113
Imaging techniques for assessing hepatic fat content in nonalcoholic fatty liver disease
Roldán-Valadéz, E., Favila, R., Martínez-López, M., Uribe, M., & Méndez‐Sánchez, N. (2008) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31850-2 · Cited by 113
Nakahara, T., Hyogo, H., Kimura, Y., Ishitobi, T., Arihiro, K., Aikata, H., Takahashi, S., & Chayama, K. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2012.01034.x · Cited by 110
Fargion, S. R., Dongiovanni, P., Guzzo, A. C., Colombo, S. F., Valenti, L. V. C., & Fracanzani, A. L. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02599.x · Cited by 108
Iron Overload Is Associated with Hepatic Oxidative Damage to DNA in Nonalcoholic Steatohepatitis
Fujita, N., Miyachi, H., Tanaka, H., Takeo, M., Nakagawa, N., Kobayashi, Y., Iwasa, M., Watanabe, S., & Takei, Y. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0725 · Cited by 107
Self-citationHamaguchi, M. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i13.1508 · Cited by 107
Yokohama, S., Tokusashi, Y., Nakamura, K., Tamaki, Y., Okamoto, S., Okada, M., Aso, K., Hasegawa, T., Aoshima, M., Miyokawa, N., et al. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i2.322 · Cited by 105
Self-citationSocha, P., Horvath, A., Vajro, P., Dziechciarz, P., Dhawan, A. K., & Szajewska, H. (2009) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31818e04d1 · Cited by 102
Nonalcoholic fatty liver disease in children
Mencin, A., & Lavine, J. E. (2010) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328342baec · Cited by 99
Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury?
Evans, C. D., Oien, K. A., MacSween, R. N. M., & Mills, P. R. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.9.689 · Cited by 94
Nar, A., & Gedik, O. (2008) · Acta Diabetologica · doi:10.1007/s00592-008-0067-2 · Cited by 90
Hyogo, H., Ikegami, T., Tokushige, K., Hashimoto, E., Inui, K., Matsuzaki, Y., Tokumo, H., Hino, F., & Tazuma, S. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00849.x · Cited by 88
Self-citationSeko, Y., Sumida, Y., Tanaka, S., Mori, K., Taketani, H., Ishiba, H., Hara, T., Okajima, A., Umemura, A., Nishikawa, T., et al. (2016) · Hepatology Research · doi:10.1111/hepr.12840 · Cited by 85
Self-citationPrimary liver cancers with nonalcoholic steatohepatitis
Hashizume, H., Sato, K., Takagi, H., Hirokawa, T., Kojima, A., Sohara, N., Kakizaki, S., Mochida, Y., Shimura, T., Sunose, Y., et al. (2007) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3282748ef2 · Cited by 83
Targher, G., Montagnana, M., Salvagno, G. L., Moghetti, P., Zoppini, G., Muggeo, M., & Lippi, G. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03068.x · Cited by 82
Li, W., Liu, Z., Sheng, C., Cheng, X., Liu, Q., & Qu, S. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-49 · Cited by 81
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
Shyangdan, D., Clar, C., Ghouri, N., Henderson, R., Gurung, T. M., Preiss, D., Sattar, N. A., Fraser, A., & Waugh, N. R. (2011) · Health Technology Assessment · doi:10.3310/hta15380 · Cited by 81
Obara, N., Ueno, Y., Fukushima, K., Nakagome, Y., Kakazu, E., Kimura, O. S., Wakui, Y., Kido, O., Ninomiya, M., Kogure, T., et al. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-008-2225-2 · Cited by 80
Self-citationHou, X., Zhu, Y., Lu, H., Chen, H., Li, Q., Jiang, S., Xiang, K., & Jia, W. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06509.x · Cited by 79
Samy, W., & Hassanian, M. A. (2011) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2011.04.008 · Cited by 78
Enjoji, M., Machida, K., Kohjima, M., Kato, M., Kotoh, K., Matsunaga, K., Nakashima, M., & Nakamuta, M. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-29 · Cited by 75
Self-citationHow should we manage patients with non‐alcoholic fatty liver disease in 2007?
Chan, H. L., de Silva, H. J., Leung, N. W. Y., Lim, S. G., Farrell, G. C., & NAFLD, T. A. W. P. O. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04977.x · Cited by 74
Tokushige, K., Hashimoto, E., Yatsuji, S., Tobari, M., Taniai, M., Torii, N., & Shiratori, K. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0237-1 · Cited by 72
Self-citationSofer, E., Boaz, M., Matas, Z., Mashavi, M., & Shargorodsky, M. (2011) · Metabolism · doi:10.1016/j.metabol.2011.01.011 · Cited by 70
Radu, C., Grigorescu, M. D., Crișan, D., Lupșor‐Platon, M., Constantin, D., & Dina, L. A. (2008) · PubMed · Cited by 68
Rodgers, M., Soares, M. O., Epstein, D. M., et al. (2011) · Health Technology Assessment · doi:10.3310/hta15suppl1-01 · Cited by 67
Sawangjit, R., Chongmelaxme, B., Phisalprapa, P., Saokaew, S., Thakkinstian, A., Kowdley, K. V., & Chaiyakunapruk, N. (2016) · Medicine · doi:10.1097/md.0000000000004529 · Cited by 66
SUMIDA, Y., Kanemasa, K., FUKUMOTO, K., YOSHIDA, N., Sakai, K., NAKASHIMA, T., & Okanoue, T. (2006) · Hepatology Research · doi:10.1016/j.hepres.2006.08.003 · Cited by 61
Self-citationHashiba, M., Ono, M., Hyogo, H., Ikeda, Y., Masuda, K., Yoshioka, R., Ishikawa, Y., Nagata, Y., Munekage, K., Ochi, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076161 · Cited by 59
Self-citationInfluence of age and gender in Japanese patients with non‐alcoholic steatohepatitis
Yatsuji, S., Hashimoto, E., Tobari, M., Tokushige, K., & Shiratori, K. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00156.x · Cited by 57
Self-citationPark, H., Hasegawa, G., Shima, T., Fukui, M., Nakamura, N., Yamaguchi, K., Mitsuyoshi, H., Minami, M., Yasui, K., Itoh, Y., et al. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.07.012 · Cited by 50
Hepatocarcinogenesis in non‐alcoholic fatty liver disease in J apan
Tokushige, K., Hashimoto, E., & Kodama, K. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12239 · Cited by 47
Self-citationBhatt, S. P., Misra, A., Sharma, M., Luthra, K., Guleria, R., Pandey, R. M., & Vikram, N. K. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0277 · Cited by 47
Mostafa, S. A., Davies, M. J., Morris, D. H., Yates, T. E., Srinivasan, B. T., Webb, D. R., Brady, E. M., & Khunti, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050931 · Cited by 42
Thameem, F., Puppala, S., Schneider, J. L., Bhandari, B., Arya, R., Arar, N. H., Vasylyeva, T. L., Farook, V. S., Fowler, S. P., Almasy, L. A., et al. (2012) · Diabetes · doi:10.2337/db11-1078 · Cited by 29
Histological Resolution of Steatohepatitis After Iron Depletion
Riquelme, A. J., Soza, A., Nazal, L., Martínez, G., Marianne Kolbach, R., Patillo, A., Arellano, M. J. S., Duarte, I., Martínez, J., Molgó, M., et al. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000034564.68307.39 · Cited by 23
Komeda, T. (2005) · Hepatology Research · doi:10.1016/j.hepres.2005.09.009 · Cited by 17
Familial Aggregation in Patients with Non-Alcoholic Steatohepatitis
Tokushige, K., Yatsuji, S., Hashimoto, E., Kabutake, A., Tobari, M., Taniai, M., & Shiratori, K. (2008) · Internal Medicine · doi:10.2169/internalmedicine.47.0476 · Cited by 14
Self-citationJSH Consensus Kobe 2009; Diagnosis and Treatment of NASH
Okanoue, T., Saibara, T., Ono, M., Sumida, Y., Hashimoto, E., Tamura, S., Yamada, G., Kawada, S., & Kudo, M. (2009) · Kanzo · doi:10.2957/kanzo.50.741 · Cited by 13
Self-citationNew discriminant score to predict the fibrotic stage of non-alcoholic steatohepatitis in Japan
Kawamura, Y., Ikeda, K., Arase, Y., Sorin, Y., Fukushima, T., Kunimoto, H., Hosaka, T., Kobayashi, M., Saitoh, S., Sezaki, H., et al. (2015) · Hepatology International · doi:10.1007/s12072-014-9605-x · Cited by 11
Cited by
Current and future pharmacological therapies for NAFLD/NASH
Sumida, Y., & Yoneda, M. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-017-1415-1 · Cited by 667
Self-citationVitamin E: Emerging aspects and new directions
Galli, F., Azzi, A., Birringer, M., Cook-Mills, J. M., Eggersdorfer, M., Frank, J., Cruciani, G., Lorkowski, S., & Özer, N. K. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.09.017 · Cited by 448
Gepner, Y., Shelef, I., Schwarzfuchs, D., Zelicha, H., Tene, L., Yaskolka Meir, A., Tsaban, G., Cohen, N., Bril, N., Rein, M., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.030501 · Cited by 279
Tokushige, K., Ikejima, K., Ono, M., Eguchi, Y., Kamada, Y., Itoh, Y., Akuta, N., Yoneda, M., Iwasa, M., Yoneda, M., et al. (2021) · Journal of Gastroenterology · doi:10.1007/s00535-021-01796-x · Cited by 270
Self-citationKASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Kang, S. H., Lee, H. W., Yoo, J.-J., Cho, Y., Kim, S. U., Lee, T. H., Jang, B. K., Kim, S. G., Ahn, S. B., Kim, H., et al. (2021) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2021.0178 · Cited by 267
Metadata
- Authors
- Watanabe, S., Hashimoto, E., Ikejima, K., Uto, H., Ono, M., Sumida, Y., Seike, M., Takei, Y., Takehara, T., Tokushige, K., Nakajima, A., Yoneda, M., Saibara, T., Shiota, G., Sakaida, I., Nakamuta, M., Mizuta, T., Tsubouchi, H., Sugano, K., & Shimosegawa, T.
- Venue
- Journal of Gastroenterology
- Published
- 2015-02-24
- Volume
- 50
- Issue
- 4
- Pages
- 364-377
- ISSN
- 0944-1174 (ISSN-L)
- 1435-5922
- OpenAlex
- W2035962070
- Cited by
- 327
- References
- 196
- FWCI
- 18.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.